Happy New Year From Dr. Bishara’s Office

Dr. Bishara and The Paragon Plastic Surgery & Med Spa offer everything you need to have your best year ever! No matter what your personal resolution may be, we have the solution!
With the help of amazing patients like you, 2013 was a great success! We hope  to help make your 2014 even better!!
January’s Special of the Month 
Clear Lift Skin Remodeling -$388 – Start the New Year Off by treating yourself to a facial treatment with no downtime.
Clear Lift Offer Expires January 31, 2014


JUVÉDERM VOLUMA XC injectable gel is the first and only filler FDA-approved to instantly add volume to the cheek area. It is designed for inject ion in the deep dermis to treat age-related facial volume loss.


Please call our office to schedule an appointment at (817) 473-2120 or email to
Happy New Year, and a Happy New You too!!
Best Wishes,
Dr. Bishara and The Paragon Plastic Surgery & Med Spa

The Food and Drug Administration has approved the cosmetic filler Juvéderm Voluma XC (hyaluronic acid/HA, Allergan).
The HA filler is the first and only filler to be approved for the temporary correction of age-related volume loss in adult patients ages 21 and older, according to a news release. The product is expected very soon, Allergan states.
Juvéderm Voluma XC, uses Allergan’s Vycross technology that results in a smooth gel. It also contains lidocaine to help numb the area during an injection procedure, the company states.
The new Juvederm Voluma XC has a long life, it has reversibility, and it is a product that really is geared to robustly treat the cheek in an efficient way.
The filler is designed to lift. What makes it different is that it uses a lower molecular weight hyaluronic acid that allows for increased cross-linking that gives the product an ideal lift capacity for the midface.
The approval follows the results of a single blinded controlled clinical trial conducted at 15 U.S. and two Canadian sites, which demonstrated efficacy and safety.
Results demonstrated that almost 50 percent of patients were maintaining optimal correction at two years. Similarly, patients demonstrated clinically significant results after almost three years.
Patients received touch-up treatment after 30 days as necessary and were followed up at one month, three months and then quarterly for up to two years, according to the study. Response was determined by two blinded investigators’ assessments at six months based on whether the patient had improved by one point or more on a validated six-month Mid-Face Volume Deficit Scale (MFVDS).
Dermatologists and plastic surgeons are going to be most concerned about patient satisfaction. 90 percent of patients reported feeling that they appeared, on average, five years younger at six months based on analysis of patient diaries. As far out as two years, patient satisfaction was at 76 percent.
The most common adverse effects seen during the clinical trial were injection site tenderness, bruising, redness, discoloration, swelling, lumps/bumps, firmness, itching, and pain that lasted approximately two to four weeks.
This news is brought to you courtesy of Dr. Mark Bishara and The Paragon Med Spa (817) 473-2120